Literature DB >> 30147069

Visualization and Analysis of miRNAs Implicated in Amyotrophic Lateral Sclerosis Within Gene Regulatory Pathways.

Hamid Hamzeiy1, Rabia Suluyayla2, Christoph Brinkrolf3, Sebastian Jan Janowski3, Ralf Hofestädt3, Jens Allmer2.   

Abstract

MicroRNAs (miRNAs), approximately 22 nucleotides long, post-transcriptionally active gene expression regulators, play active roles in modulating cellular processes. Gene regulation and miRNA regulation are intertwined and the main aim of this study is to facilitate the analysis of miRNAs within gene regulatory pathways. VANESA enables the reconstruction of biological pathways and supports visualization and simulation. To support integrative miRNA and gene pathway analyses, a custom database of experimentally proven miRNAs, integrating data from miRBase, TarBase and miRTarBase, was added to DAWIS-M.D., which is the main data source for VANESA. Analysis of human KEGG pathways within DAWIS-M.D. showed that 661 miRNAs (~1/3 recorded human miRNAs) lead to 65,474 interactions. hsa-miR-335-5p targets most genes in our system (2,544); while the most targeted gene (with 71 miRNAs) is NUFIP2 (Nuclear Fragile X Mental Retardation Protein Interacting Protein 2). Amyotrophic Lateral Sclerosis (ALS), a complex neurodegenerative disease, was chosen as a proof of concept model. Using our system, it was possible to reduce the initially several hundred genes and miRNAs associated with ALS to eight genes, 19 miRNAs and 31 interactions. This highlights the effectiveness of the implemented system to distill important information from otherwise hard to access, highly convoluted and vast regulatory networks.

Entities:  

Keywords:  KEGG; amyotrophic lateral sclerosis; gene expression regulation; metabolic networks and pathways; miRBase; miRTarBase; microRNAs

Mesh:

Substances:

Year:  2018        PMID: 30147069

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  7 in total

Review 1.  MicroRNA Targeting.

Authors:  Hossein Ghanbarian; Mehmet Taha Yıldız; Yusuf Tutar
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases.

Authors:  Giulia Gentile; Giovanna Morello; Valentina La Cognata; Maria Guarnaccia; Francesca Luisa Conforti; Sebastiano Cavallaro
Journal:  J Pers Med       Date:  2022-05-10

Review 3.  MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases.

Authors:  Mariano Catanesi; Michele d'Angelo; Maria Grazia Tupone; Elisabetta Benedetti; Antonio Giordano; Vanessa Castelli; Annamaria Cimini
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

Review 4.  Systems analysis of miRNA biomarkers to inform drug safety.

Authors:  Amy L Schofield; Joseph P Brown; Jack Brown; Ania Wilczynska; Catherine Bell; Warren E Glaab; Matthias Hackl; Lawrence Howell; Stephen Lee; James W Dear; Mika Remes; Paul Reeves; Eunice Zhang; Jens Allmer; Alan Norris; Francesco Falciani; Louise Y Takeshita; Shiva Seyed Forootan; Robert Sutton; B Kevin Park; Chris Goldring
Journal:  Arch Toxicol       Date:  2021-09-12       Impact factor: 5.153

5.  Comparative Transcriptome Provides a Systematic Perspective on Epstein-Barr Virus-Associated Gastric Carcinoma Cell Lines.

Authors:  Jun-Ting Huang; Jian-Ning Chen; Yuan-Hua Bi; Li-Ping Gong; Jing-Yue Zhang; Yu DU; Chun-Kui Shao
Journal:  Onco Targets Ther       Date:  2021-10-23       Impact factor: 4.147

Review 6.  The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis.

Authors:  Jinmeng Liu; Fenghua Zhou; Yingjun Guan; Fandi Meng; Zhenhan Zhao; Qi Su; Weiwei Bao; Xuemei Wang; Jiantao Zhao; Zijun Huo; Lingyun Zhang; Shuanhu Zhou; Yanchun Chen; Xin Wang
Journal:  Cells       Date:  2022-02-07       Impact factor: 6.600

7.  Downregulation of miR-335-5P in Amyotrophic Lateral Sclerosis Can Contribute to Neuronal Mitochondrial Dysfunction and Apoptosis.

Authors:  Noemi De Luna; Joana Turon-Sans; Elena Cortes-Vicente; Ana Carrasco-Rozas; Ignacio Illán-Gala; Oriol Dols-Icardo; Jordi Clarimón; Alberto Lleó; Eduard Gallardo; Isabel Illa; Ricardo Rojas-García
Journal:  Sci Rep       Date:  2020-03-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.